New York has confirmed a case of a South African coronavirus version of a resident of Nassau County.

The case was discovered through sequencing in a commercial laboratory in the city, and no other details were given. Announcement Posted on Sunday, such as patient status, travel history or when the case was confirmed.

Andrew Cuomo reported statewide positivity and hospitalization, which were allowed to proceed upon reopening, but amid the news of the edition, residents doubled down on mitigation measures such as face masks, hand hygiene and social balance requested.

Dr. FAUCI: IT’s ‘POSSIBLE’ AMERICANS will be like the days coming in May 2222.

“… With the discovery of a case of the South African version in the state, it is more important than ever for New Yorkers to be vigilant, wear masks, wash hands and be socially distant.” Cuomo said, in a statement posted on Sunday. “We are in a race right now – between our ability to vaccinate and these variants that are actively trying to spread – and we will only win that race if we stay smart and disciplined.”

The news follows a separate announcement from last Monday, when the state confirmed the version in a patient who was transferred from Connecticut to a city hospital. At the time, Cuomo stated that there is no further evidence related to the case.

Get box news app

Several mutated versions of the virus have caused significant concern among experts as they have been shown to reduce vaccine efficacy, including variants previously identified in South Africa, B.1.351 and the United Kingdom, B.1.1.7. Are included. These strains include changes with surface spike proteins that allow pathogens to bind more tightly to healthy cells.

data from Centers for Disease Control and Prevention The notes record 22 cases of type B.1.351, with 22 cases in ten states, with 1,660 cases of strain B.1.1.7 in 44 states, which are projected to become major strains in the US by March.

Many companies are searching for different booster shots in the bid for greater protection against strains. Protection by both Pfizer and Modern, particularly against the B.1.351 variant, remains unclear. Studies have shown that the variant reduced Pfizer’s vaccination power by nearly two-thirds, while Modern showed a six-fold reduction in neutralizing antibodies.